Skip to main content
. 2021 May 24;13:341–351. doi: 10.2147/BCTT.S274283

Figure 1.

Figure 1

The most important factors affecting the gonadotoxicity risk in women with breast cancer patients receiving chemotherapy.

Abbreviations: AMH, anti-Mullerian hormone; GnRHa, gonadotropin-releasing hormone analog.